AIM

#4751
AIM ImmunoTech Inc. Common Stock
0.3 9 USD
-7.14%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
0.39
0.39
1年のレンジ
0.21
20.35
1日の変化
-7.14%
月次変化
-23.54%
6か月変化
-75.65%
1年の変化
-95.41%
以前の終値
0.4 2
Open
0.3 9
安値
0.3 9
High
0.3 9
ボリューム
233
チャート全体を表示 Full chart

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 5.68 M
  • Employee 21
  • Founded N/A
  • CEO N/A
  • Website www.aimimmuno.com
  • Headquarter Delaware, United States
  • FIGI BBG000JL6Z80
  • Industry 生物工学
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.13
売上高対価格比率
20.76

AIM ImmunoTech Inc. Common Stock

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

ニュース